Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with cardiometabolic disease, but recent systematic reviews and meta-analyses of longitudinal studies that quantify these associations are lacking. OBJECTIVE AND RATIONALE: Is PCOS a risk factor for cardiometabolic disease? SEARCH METHODS: We searched from inception to September 2019 in MEDLINE and EMBASE using controlled terms (e.g. MESH) and text words for PCOS and cardiometabolic outcomes, including cardiovascular disease (CVD), stroke, myocardial infarction, hypertension (HT), type 2 diabetes (T2D), metabolic syndrome and dyslipidaemia. Cohort studies and case–control studies comparing the prevalence of T2D, HT, fatal or non-fatal CVD and/or lipid concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TGs) between women with and without PCOS of ≥18 years of age were eligible for this systematic review and meta-analysis. Studies were eligible regardless of the degree to which they adjusted for confounders including obesity. Articles had to be written in English, German or Dutch. Intervention studies, animal studies, conference abstracts, studies with a follow-up duration less than 3 years and studies with less than 10 PCOS cases were excluded. Study selection, quality assessment (Newcastle–Ottawa Scale) and data extraction were performed by two independent researchers. OUTCOMES: Of the 5971 identified records, 23 cohort studies were included in the current systematic review. Women with PCOS had increased risks of HT (risk ratio (RR): 1.75, 95% CI 1.42 to 2.15), T2D (RR: 3.00, 95% CI 2.56 to 3.51), a higher serum concentration of TC (mean difference (MD): 7.14 95% CI 1.58 to 12.70 mg/dl), a lower serum concentration of HDL-C (MD: −2.45 95% CI −4.51 to −0.38 mg/dl) and increased risks of non-fatal cerebrovascular disease events (RR: 1.41, 95% CI 1.02 to 1.94) compared to women without PCOS. No differences were found for LDL-C (MD: 3.32 95% CI −4.11 to 10.75 mg/dl), TG (MD 18.53 95% CI −0.58 to 37.64 mg/dl) or coronary disease events (RR: 1.78, 95% CI 0.99 to 3.23). No meta-analyses could be performed for fatal CVD events due to the paucity of mortality data. WIDER IMPLICATIONS: Women with PCOS are at increased risk of cardiometabolic disease. This review quantifies this risk, which is important for clinicians to inform patients and to take into account in the cardiovascular risk assessment of women with PCOS. Future clinical trials are needed to assess the ability of cardiometabolic screening and management in women with PCOS to reduce future CVD morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PCOS is associated with increased co-morbidities including obesity, infertility, pregnancy complications, depression and anxiety, metabolic syndrome, diabetes, reproductive cancers and cardiovascular disease [3, 7, 8, 10–13].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredIn the citing paper
“Women with PCOS have a more unfavorable lipid profile than women without PCOS.62,63”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 2×
“Sensitivity analyses including highquality studies and based on the diagnostic criteria for PCOS (NIH 1990 criteria (Zawadzki and Dunaif, 1992), AE-PCOS criteria (Azziz et al., 2009) or Rotterdam 2003 criteria (Rotterdam ESHRE/ASRMSponsored PCOS Consensus Workshop Group, 2004)) were performed if three or more studies…”
MethodTeede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Self-citationInsulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358 · cited 1×
“Intrinsic insulin resistance, often present and linked to hyperandrogenism in women with PCOS, is also associated with cardiometabolic disease (Ginsberg, 2000; Baptiste et al., 2010; Stepto et al., 2013; Cassar et al., 2016).”
BackgroundMoran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Beta Cell Dysfunction and Insulin Resistance
Cerf, M. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00037 · Cited by 964 · cited 1×
“Insulin resistance leads to increased lipolysis from adipose tissue and facilitates dyslipidaemia, which has a toxic effect on the pancreatic islet cells (Cerf, 2013).”
BackgroundLim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939 · cited 1×
“This makes it impossible to study whether the effects are independent of obesity, an important confounder in the relationship between PCOS and cardiometabolic risk (Lim et al., 2012).”
BackgroundAndermann, A. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.050112 · Cited by 903 · cited 3×
“Screening should only be performed if it leads to earlier recognition of modifiable cardiometabolic risk factors and if treatment leads to better health outcomes (Andermann et al., 2008).”
BackgroundInfluentialCardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · cited 2×
“Insulin clamp studies have shown that women with PCOS also have intrinsic insulin resistance, independent of weight, suggesting a higher T2D risk, even in the absence of obesity (Stepto et al., 2013; Cassar et al., 2016).”
BackgroundWhat is heterogeneity and is it important?
Fletcher, J. (2007) · BMJ · doi:10.1136/bmj.39057.406644.68 · Cited by 546
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Talbott, E., Guzick, D., Clerici, A., Berga, S., Detre, K., Weimer, K., & Kuller, L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 504 · cited 9×
“Five studies (Talbott et al., 1995; Cibula et al., 2000; Schmidt et al., 2011; Hudecova et al., 2011a,b; Carmina et al., 2013) were included in the meta-analysis for TG concentration (mg/dl).”
BackgroundResultInfluential2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 486
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Rojas, J., Chávez, M., Olivar, L., Rojas, M., Morillo, J., Mejías, J., Calvo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 467
Observational research, randomised trials, and two views of medical science
Vandenbroucke, J. P. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050067 · Cited by 416 · cited 1×
“The heterogeneity is likely to be based on an overestimation of the effect in the retrospective studies (Vandenbroucke, 2008).”
BackgroundCassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · cited 2×
“Insulin clamp studies have shown that women with PCOS also have intrinsic insulin resistance, independent of weight, suggesting a higher T2D risk, even in the absence of obesity (Stepto et al., 2013; Cassar et al., 2016).”
BackgroundEpidemiology and Adverse Cardiovascular Risk Profile of Diagnosed Polycystic Ovary Syndrome
Lo, J. C., Feigenbaum, S. L., Yang, J., Pressman, A. R., Selby, J. V., & Go, A. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2430 · Cited by 414
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391
Tierney, J. F., Vale, C., Riley, R., Smith, C. T., Stewart, L., Clarke, M., & Rovers, M. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001855 · Cited by 361 · cited 1×
“The eligible studies were, however, performed many years back, which may present a barrier to retrieving the data (Tierney et al., 2015).”
BackgroundInsulin and hyperandrogenism in women with polycystic ovary syndrome
Baptiste, C. G., Battista, M.-C., Trottier, A., & Baillargeon, J.-P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.010 · Cited by 355
The InterAct Consortium (2013) · Diabetologia · doi:10.1007/s00125-012-2715-x · Cited by 348
Poly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes
Oh, Y. S., Bae, G. D., Baek, D. J., Park, E.-Y., & Jun, H.-S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00384 · Cited by 306
Obesity and PCOS: Implications for Diagnosis and Treatment
Legro, R. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1328878 · Cited by 280 · cited 1×
“However, there is no evidence that PCOS is caused by obesity (Legro, 2012).”
BackgroundCibula, D. (2000) · Human Reproduction · doi:10.1093/humrep/15.4.785 · Cited by 267 · cited 12×
“Five studies (Talbott et al., 1995; Cibula et al., 2000; Schmidt et al., 2011; Hudecova et al., 2011a,b; Carmina et al., 2013) were included in the meta-analysis for TG concentration (mg/dl).”
BackgroundInfluentialSchmidt, J., Landin-Wilhelmsen, K., Brännström, M., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1677 · Cited by 241 · cited 13×
“Five studies (Talbott et al., 1995; Cibula et al., 2000; Schmidt et al., 2011; Hudecova et al., 2011a,b; Carmina et al., 2013) were included in the meta-analysis for TG concentration (mg/dl).”
BackgroundMethodInfluentialLink between insulin resistance and hypertension: What is the evidence from evolutionary biology?
Zhou, M.-S., Wang, A., & Yu, H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-12 · Cited by 210
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200 · cited 16×
“Four studies scored low risk of bias on all eight criteria (nine stars), indicating these studies were of the highest quality (Table III) (Morgan et al., 2012; Kazemi Jaliseh et al., 2017; Rubin et al., 2017; Glintborg et al., 2018).”
BackgroundResultInfluentialRubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01354 · Cited by 195 · cited 12×
“Four studies scored low risk of bias on all eight criteria (nine stars), indicating these studies were of the highest quality (Table III) (Morgan et al., 2012; Kazemi Jaliseh et al., 2017; Rubin et al., 2017; Glintborg et al., 2018).”
BackgroundInfluentialOllila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182 · cited 1×
“…could be used as a window of opportunity to prevent long-term cardiometabolic consequences by increasing awareness about the importance of a healthy lifestyle, and providing support to optimize modifiable lifestyle factors such as smoking and obesity (Piepoli et al., 2016; van Dammen et al., 2018).”
BackgroundOllila, M.-M. E., West, S., Keinänen-Kiukaanniemi, S., Jokelainen, J., Auvinen, J., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew329 · Cited by 165
Women-Specific Factors to Consider in Risk, Diagnosis and Treatment of Cardiovascular Disease
Harvey, R. E., Coffman, K. E., & Miller, V. M. (2015) · Women s Health · doi:10.2217/whe.14.64 · Cited by 148 · cited 1×
“PCOS has been suggested to be a specific female reproductive risk factor for cardiometabolic diseases such as type 2 diabetes (T2D), myocardial infarction and stroke, which are the leading causes of death in women (Dokras, 2013; Harvey et al., 2015).”
BackgroundPolycystic Ovary Syndrome and Risk for Long-Term Diabetes and Dyslipidemia
Wang, E. T., Calderon-Margalit, R., Cedars, M. I., Daviglus, M. L., Merkin, S. S., Schreiner, P. J., Sternfeld, B., Wellons, M., Schwartz, S. M., Lewis, C. E., et al. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31820209bb · Cited by 146 · cited 5×
“, 2019), three studies the NIH criteria (Wang et al., 2011; Ramezani Tehrani et al., 2015; Kazemi Jaliseh et al., 2017), five studies used ICD codes (Lo et al.”
BackgroundInfluentialMorgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136
Lipotoxicity in the Pancreatic Beta Cell: Not Just Survival and Function, but Proliferation as Well?
Sharma, R. B., & Alonso, L. C. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0492-2 · Cited by 136
Cardiovascular disease risk in women with PCOS
Dokras, A. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.009 · Cited by 132 · cited 1×
“PCOS has been suggested to be a specific female reproductive risk factor for cardiometabolic diseases such as type 2 diabetes (T2D), myocardial infarction and stroke, which are the leading causes of death in women (Dokras, 2013; Harvey et al., 2015).”
BackgroundMeun, C., Franco, O. H., Dhana, K., Jaspers, L., Muka, T., Louwers, Y., Ikram, M. A., Fauser, B. C. J. M., Kavousi, M., & Laven, J. S. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02421 · Cited by 126
Self-citationYarmolinsky, J., Bordin Barbieri, N., Weinmann, T., Ziegelmann, P. K., Duncan, B. B., & Schmidt, M. I. (2016) · Scientific Reports · doi:10.1038/srep17714 · Cited by 118
van Dammen, L., Wekker, V., van Oers, A. M., Mutsaerts, M. A. Q., Painter, R. C., Zwinderman, A. H., Groen, H., van de Beek, C., Muller Kobold, A. C., Kuchenbecker, W. K. H., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0190662 · Cited by 102
Self-citationGlueck, C. J., Dharashivkar, S., Wang, P., Zhu, B., Gartside, P. S., Tracy, T., & Sieve, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.03.010 · Cited by 99
Merz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87
Kazemi Jaliseh, H., Ramezani Tehrani, F., Behboudi-Gandevani, S., Hosseinpanah, F., Khalili, D., Cheraghi, L., & Azizi, F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.09.004 · Cited by 80
Not all women diagnosed with PCOS share the same cardiovascular risk profiles
Jovanovic, V. P., Carmina, E., & Løbo, R. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.021 · Cited by 78 · cited 1×
“The publication of anonymized datasets and standardized registration of the PCOS phenotype (presence of clinical or biochemical hyperandrogenism; menstrual irregularities or polycystic ovaries on ultrasonography) and obesity among studies would allow us to investigate which women diagnosed with PCOS have an increased…”
BackgroundRisk of cardiovascular events in patients with polycystic ovary syndrome.
Iftikhar, S., Collazo–Clavell, M. L., Roger, V. L., Sauver, J. L. S., Brown, R. D., Cha, S., & Dj, R. (2012) · PubMed · Cited by 73
Ramezani Tehrani, F., Montazeri, S. A., Hosseinpanah, F., Cheraghi, L., Erfani, H., Tohidi, M., & Azizi, F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137609 · Cited by 67
Hudecova, M., Holte, J., Olovsson, M., Larsson, A., Berne, C., & Sundstrom-Poromaa, I. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.006 · Cited by 61
Karabulut, A., Yaylali, G. F., Demirlenk, S., Sevket, O., & Acun, A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.589929 · Cited by 61 · cited 1×
“Both obesity and PCOS are linked to a higher metabolic and cardiovascular disease (CVD) risk, but there is conflicting evidence whether these are independent associations (Moran et al., 2010; Karabulut et al., 2012).”
BackgroundCarmina, E., Campagna, A. M., & Lobo, R. A. (2013) · Human Reproduction · doi:10.1093/humrep/det119 · Cited by 56 · cited 11×
“Five studies (Talbott et al., 1995; Cibula et al., 2000; Schmidt et al., 2011; Hudecova et al., 2011a,b; Carmina et al., 2013) were included in the meta-analysis for TG concentration (mg/dl).”
BackgroundMethodResultInfluentialTalbott, E. O., Zborowski, J. V., Rager, J. R., Kip, K. E., Xu, X., & Orchard, T. J. (2007) · Journal of Women's Health · doi:10.1089/jwh.2006.0098 · Cited by 55 · cited 5×
“, 2018) and eight used a definition based on the presence of either hyperandrogenism, hirsutism or menstrual irregularities/anovulation (Talbott et al., 1995; Cibula et al., 2000; Wild et al., 2000; Lunde and Tanbo, 2007; Talbott et al., 2007; Merz et al., 2016; Ollila et al., 2017; Meun et al., 2018) (Tables I and II…”
BackgroundResultInfluentialOveruse of Health Care Services
Lipitz‐Snyderman, A., & Bach, P. B. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6181 · Cited by 53 · cited 1×
“Screening for CVD in a relatively low-risk population may be associated with low yield of preventable cases, considerable costs and possible harms incurred by overdiagnosis (Lipitz-Snyderman and Bach, 2013).”
BackgroundHudecova, M., Holte, J., Olovsson, M., Larsson, A., Berne, C., & Poromaa, I. S. (2011) · Human Reproduction · doi:10.1093/humrep/der065 · Cited by 53
Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype
Bil, E., Dilbaz, B., Cirik, D. A., Ozelci, R., Ozkaya, E., & Dilbaz, S. (2016) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12985 · Cited by 53 · cited 1×
“The publication of anonymized datasets and standardized registration of the PCOS phenotype (presence of clinical or biochemical hyperandrogenism; menstrual irregularities or polycystic ovaries on ultrasonography) and obesity among studies would allow us to investigate which women diagnosed with PCOS have an increased…”
BackgroundValerio, L., Peters, R. J., Zwinderman, A. H., & Pinto‐Sietsma, S. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004260 · Cited by 50
Lunde, O., & Tanbo, T. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701705189 · Cited by 43 · cited 8×
“Eight studies were included in the meta-analysis for non-fatal cerebrovascular events (Wild et al., 2000; Lo et al., 2006; Lunde and Tanbo, 2007; Schmidt et al., 2011; Iftikhar et al., 2012; Hart and Doherty, 2015; Glintborg et al., 2018; Meun et al., 2018).”
BackgroundInfluentialDiagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
Andersen, M., & Glintborg, D. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0237 · Cited by 36 · cited 1×
“Given the increase in cardiometabolic risk, it is understandable that cardiometabolic screening of women with PCOS is regularly suggested in international guidelines (Huang and Coviello, 2012; Andersen and Glintborg, 2018).”
BackgroundHuang, G. T.-W., & Coviello, A. D. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835a000e · Cited by 35 · cited 1×
“Given the increase in cardiometabolic risk, it is understandable that cardiometabolic screening of women with PCOS is regularly suggested in international guidelines (Huang and Coviello, 2012; Andersen and Glintborg, 2018).”
BackgroundTuñón, J., Martín-Ventura, J. L., Blanco‐Colio, L. M., Tarín, N., & Egido, J. (2007) · PubMed Central · Cited by 32
Assessment of changes to screening programmes: why randomisation is important
Bell, K., Bossuyt, P. M., Glasziou, P., & Irwig, L. (2015) · BMJ · doi:10.1136/bmj.h1566 · Cited by 22 · cited 2×
“A randomized trial comparing screening of established cardiometabolic risk factors, such as HT, T2D and dyslipidaemia, in women with PCOS to no screening, in combination with long-term follow-up to evaluate the effect of treatment on cardiometabolic outcomes (blood pressure, glucose metabolism and lipids) and event ra…”
BackgroundNew diagnosis of polycystic ovary syndrome
McLuskie, I., & Newth, A. (2017) · BMJ · doi:10.1136/bmj.i6456 · Cited by 20 · cited 1×
“It is often diagnosed in the reproductive phase of life when women with PCOS are confronted with infertility, or because of symptoms of hyperandrogenism, including acne, alopecia androgenica and hirsutism (McLuskie and Newth, 2017).”
BackgroundUdesen, P. B., Sørensen, A. E., Joglekar, M. V., Hardikar, A. A., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0478-7 · Cited by 10 · cited 8×
“The criteria used to diagnose PCOS were the Rotterdam criteria in seven studies (Schmidt et al., 2011; Hudecova et al., 2011a,b, 2010; Iftikhar et al., 2012; Carmina et al., 2013; Udesen et al., 2019), three studies the NIH criteria (Wang et al.”
BackgroundMethodInfluentialEndothelial function in patients with polycystic ovary syndrome: a long-term follow-up study
Hudecova, M., Holte, J., Olovsson, M., Lind, L., & Poromaa, I. S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.048 · Cited by 9 · cited 2×
“Seven studies (Talbott et al., 1995; Cibula et al., 2000; Hudecova et al., 2010; Schmidt et al., 2011; Carmina et al., 2013; Ramezani Tehrani et al., 2015; Udesen et al., 2019) were included in the meta-analysis for TC concentration (mg/dl).”
Background
Research works printed but not linked: 1
- Zawadzki J, Dunaif A. Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach. Boston: Blackwell Scientific Publications, 1992.
Cited by
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Current analyses have strengthened the evidence for increased risk for different cardiovascular disease outcomes in individuals with PCOS 13,49 .”
Self-citationZhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
“It also highlights evidence which suggests that the psychological impact associated with PCOS is under-appreciated in clinical care [4, 5], and that few women are satisfied with the mental health support they receive [6, 7].”
BackgroundAutophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 305
Metadata
- Authors
- Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- Ziekenhuis Amstelland (NL)
- University Medical Center Utrecht (NL)
- Amsterdam University Medical Centers (NL)
- Erasmus MC (NL)
- Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands
- University Medical Center Groningen (NL)
- Corresponding author
- Wekker, V
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-09-30
- Volume
- 26
- Issue
- 6
- Pages
- 942-960
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- PMC
- PMC7600286
- OpenAlex
- W3090224534
- Cited by
- 425
- References
- 71
- Citations by year
- 2026: 80 · 2025: 89 · 2024: 76 · 2023: 89 · 2022: 48 · 2021: 39 · 2020: 3
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction Update (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- Dutch Heart Foundation (2013T085)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, cardiometabolic disease, cardiovascular disease, stroke, myocardial infarction, hypertension, type 2 diabetes, metabolic syndrome, dyslipidemia, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, women's health, long-term risk factors, cardiovascular risk stratification
- MeSH terms
- Cardiometabolic Risk Factors, Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Obesity, Polycystic Ovary Syndrome, Risk Factors, Triglycerides, Case-Control Studies, Stroke, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.